Transcatheter therapy of structural heart disease is advancing rapidly. Due to the less invasive approach, transcatheter techniques have replaced surgery as the standard procedure for atrial septal defect and patent foramen ovale closure.

Evolving interventional techniques allow treatment of paravalvular leaks, ventricular septal defects and valve replacement, especially the rapid evolution and newer indications for transcatheter aortic valve replacement (TAVR).

Related Articles


Antithrombotics in LM and Bifurcation PCI

Charalampos Varlamos, Ioannis Lianos, Despoina-Rafailia Benetou,


Citation: US Cardiology Review 2021;15:e11.

Concomitant LV Outflow Tract Obstruction and Aortic Stenosis

Priya Bansal, Hamza Lodhi, Adithya Mathews,


Citation: Interventional Cardiology Review 2021;16:e11.

APSC Consensus Recommendations for MitraClip in MR

Yeo Khung Keong, Jack Wei Chieh Tan, David WM Muller,


Citation: European Cardiology Review 2021;16:e25.

The ISCHEMIA Trial: What is the Message for the Interventionalist?

Emmanuel Ako, Sukhjinder Nijjer, Abtehale Al-Hussaini,


Citation: European Cardiology Review 2021;16:e24.